Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV calcium gluconate for prevention of ECG abnormalities in severe hyperkalemia
TCTR20261007023Phase 4Not yet recruiting
- Sponsor
- Vajira Hospital
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of calcium gluconate in hyperkalemia, sponsored by Vajira Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
calcium gluconate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on TCTR20261007023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261007023.